Skip to content

Intensive Nutritional Counseling in Head-neck Cancer Patients Undergoing Radiotherapy

Intensive Nutritional Counseling in Head-neck Cancer Patients Undergoing Radiotherapy: a Randomized, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02055833
Enrollment
159
Registered
2014-02-05
Start date
2013-09-30
Completion date
2016-08-31
Last updated
2025-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head-neck Cancer

Brief summary

In head-neck cancer patients undergoing radiotherapy (RT) malnutrition is associated with impaired quality of life, reduced survival, more frequent treatment interruptions and dose reductions. The international guidelines recommend early nutritional support in the presence of nutritional risk, as it allows preventing or treating malnutrition and improving the clinical outcomes, as well as the tolerability of oncologic treatments. Previous nutritional intervention trials in head-neck cancer patients have been conducted on small samples and did not clarify the role of oral nutritional supplements (ONS). Accordingly, although current guidelines recommend as grade A the use of ONS associated with dietary counseling for head-neck cancer patients undergoing RT, the efficacy of this nutritional intervention still needs to be evaluated in adequately sized and randomized clinical trials.

Interventions

Intensive nutritional counseling: nutritional counseling + oral nutritional supplements

OTHERNutritional counseling

Nutritional counseling

Sponsors

Nestlè Health Science
CollaboratorUNKNOWN
Akern Srl
CollaboratorINDUSTRY
Fondazione IRCCS Policlinico San Matteo di Pavia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* newly diagnosed head-neck cancer * indication to radiotherapy * Eastern Cooperative Oncology Group performance status \<=2 * availability to planned measurements and to written informed consent.

Exclusion criteria

* age \<18 years * ongoing artificial nutrition * refusal

Design outcomes

Primary

MeasureTime frameDescription
Body weight6 weeksChange in body weight at the end of radiotherapy (after 6 weeks)

Secondary

MeasureTime frameDescription
Body weight3 monthsChange in body weight at 1 month since the end of radiotherapy
Quality of life5 monthsTrends in quality of life during the study (assessment: at the end of radiotherapy; at 1 month and at 3 months since the end of radiotherapy)
Handgrip strength5 monthsTrends in handgrip strength during the study (assessment: at the end of radiotherapy; at 1 month and at 3 months since the end of radiotherapy)
Phase angle5 monthsTrends in phase angle (as surrogate of body composition) during the study (assessment: at the end of radiotherapy; at 1 month and at 3 months since the end of radiotherapy)

Other

MeasureTime frameDescription
Feasibility of radiotherapy6 weeksDescribed as: number of interruptions \>5 days; total duration (days); dose reduction

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026